Michael Schwartz at Troutman Pepper Locke LLP has extensive experience representing companies and individuals facing investigations and litigation by state and federal agencies. Schwartz has expertise in the healthcare space, with a strong focus on the pharma, medical device and service provider industries; notably having represented Janssen, a subsidiary of Johnson & Johnson. Schwartz also has expertise in the construction and government contracting spaces, and advised JAS Group Enterprises as well as its CEO.
Legal 500 Editorial commentary
- Profile
Accolades
Philadelphia Elite
Key clients
- Johnson & Johnson/Janssen
- Anesthesiology Consultants Exchange
- Henry Schein, Inc.
- JAS Group Enterprises and its CEO
Work highlights
Represented Jannsen in qui tam litigation involving allegations that the client's off-label marketing of two products used to treat HIV/Aids violated the FCA and federal Anti-Kickback Statute.
Represented Anesthesiology Consultants Exchange, P.C. (ACE) in the defense of a False Claims Act case in the U.S. District Court for the Eastern District of Tennessee involving allegations of improper billing of Medicare and Medicaid for multiple overlapping surgeries, and that unnecessarily long anaesthesia was given to patients.
Represented a healthcare products & services client and its subsidiary in a qui tam False Claims Act suit brought by a competitor company.